Ultrasonic Cavitation for Stem Cell Isolation from Adipose Tissue
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating stem cells from adipose tissue using enzymes like collagenase result in high cell death, contamination, and regulatory challenges, making them unsuitable for transplantation and potentially requiring drug approval.
Innovation Solution
The use of ultrasonic cavitation to break down adipose tissue and lyse mature adipocytes, maintaining the viability of stromal/stem cells and extracellular matrix, without the need for enzymes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If enzyme treatment (collagenase) is used to isolate stem cells from adipose tissue, then the collagen bonds are dissolved and stem cells are released, but cell death increases and stem cell viability decreases
Solution Approach 1:
The patent replaces the chemical/enzymatic system (collagenase) with a mechanical system (ultrasonic cavitation) to achieve tissue disruption and cell isolation. The ultrasonic waves create cavitation bubbles that mechanically disrupt adipose tissue and dissolve collagen bonds through physical forces rather than enzymatic degradation, thereby isolating stem cells while preserving their viability.
Solution Approach 2:
The patent changes the fundamental parameter of the isolation process from chemical (enzyme-based) to physical (ultrasonic-based). By altering the mechanism from biochemical degradation to mechanical disruption through controlled cavitation, the process achieves effective tissue breakdown without the cytotoxic effects of enzymes, maintaining stem cell integrity and viability.
2Productivity
If enzyme treatment is used to isolate stem cells, then stem cells are released from tissue, but contamination with enzymes occurs making cells unsuitable for transplantation
Solution Approach 1:
The patent eliminates enzyme contamination by replacing the enzymatic isolation process with a mechanical ultrasonic cavitation process. This substitution removes the source of contamination (enzymes) while maintaining effective tissue disruption and cell release, producing a cleaner cell preparation suitable for transplantation without requiring additional purification steps.
Solution Approach 2:
The patent converts the potentially harmful effect of mechanical cavitation (which could damage cells) into a beneficial process by carefully controlling parameters to achieve selective disruption of adipose tissue and collagen while preserving stem cell integrity. The mechanical force that could be harmful is precisely controlled to benefit the isolation process without contamination.
3Ease of manufacture
If enzyme treatment is used for stem cell isolation, then tissue is broken down and cells are released, but regulatory approval becomes more difficult requiring drug approval
Solution Approach 1:
The patent replaces the pharmaceutical/enzymatic approach with a physical device-based approach (ultrasonic generator). This substitution transitions the process from requiring drug approval (enzymatic treatment) to device regulation (ultrasonic generation), simplifying the regulatory pathway for clinical application while maintaining effective tissue disruption and cell isolation capabilities.
Solution Approach 2:
The ultrasonic device performs the tissue disruption function that previously required external enzymatic agents. The mechanical energy from the ultrasonic generator directly accomplishes what enzymes did, making the process self-contained without requiring additional pharmaceutical substances, thereby reducing regulatory complexity.
4Productivity
If enzyme treatment is used to isolate stem cells, then collagen bonds are dissolved, but cellular debris increases and stem cell purity decreases
Solution Approach 1:
The patent replaces enzymatic degradation with mechanical cavitation to achieve cleaner cell isolation. The ultrasonic cavitation process selectively disrupts adipose tissue and dissolves collagen through physical forces, releasing stem cells with minimal degradation of cellular structures. This results in lower cellular debris and higher stem cell purity compared to enzyme treatment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively isolates a stromal vascular fraction with viable stem cells, reducing cell death and contamination, and avoids regulatory issues, allowing for the use of adipose tissue-derived stem cells in therapeutic applications.
Implementation Method 1
treating the adipose tissue with ultrasonic cavitation breaks up the adipose tissue and lyses mature adipocytes
Implementation Method 2
treating the adipose tissue with ultrasonic cavitation
Data Source
AI summary
In one embodiment, the present invention relates to a non-enzymatic method for isolating stem cells from adipose tissue, wherein the method comprises treating adipose tissue with ultrasonic cavitation to break up the adipose tissue and lyses mature adipocytes, resulting in a stromal vascular fraction containing viable stromal/stem cells.


